✦ LIBER ✦

Multidrug resistance in a small cell lung cancer line: Rapid selection with etoposide and differential chemosensitization with cyclosporin A

Book ID: 122867722
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 154 KB
Volume: 10
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(93)90426-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antigens associated with multidrug resis

Antigens associated with multidrug resistance in H69AR, a small cell lung cancer cell line

📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Peripheral blood mononuclear cells expre

Peripheral blood mononuclear cells express antigens associated with multidrug resistance in a small cell lung cancer cell line

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 152 KB

A study of cross-resistance pattern and

A study of cross-resistance pattern and expression of molecular markers of multidrug resistance in a human small-cell lung-cancer cell line selected with doxorubicin

✍ Rosanna Supino; Monica Binaschi; Giovanni Capranico; Romolo A. Gambetta; Elena S 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 920 KB

## Abstract A doxorubicin‐resistant variant of the human small‐cell lung‐cancer cell line N592 was selected by __in vitro__ continuous exposure to increasing drug concentrations. The aim of this study was to examine the cross‐resistance pattern, cellular pharmacokinetics of doxorubicin and expressi

Circumvention of multidrug resistance by

Circumvention of multidrug resistance by a quinoline derivative, MS-209, in multidrug-resistant human small-cell lung cancer cells and its synergistic interaction with cyclosporin A or verapamil

✍ Punya Shrivastava; Masaki Hanibuchi; Seiji Yano; Prahlad Parajuli; Takashi Tsuru 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 194 KB

Combination of cyclosporin A and buthion

Combination of cyclosporin A and buthionine sulfoximine (BSO) as a pharmacological strategy for circumvention of multidrug resistance in small cell lung cancer cell lines selected for resistance to doxorubicin

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Annamycin circumvents resistance mediate

Annamycin circumvents resistance mediated by the multidrug resistance-associated protein (MRP) in breast MCF-7 and small-cell lung UMCC-1 cancer cell lines selected for resistance to etoposide

✍ Roman Perez-Soler; Nouri Neamati; Yiyu Zou; Erasmus Schneider; L. Austin Doyle; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 144 KB 👁 2 views

Annamycin (Ann) is a highly lipophilic anthracycline antibiotic that has been shown to circumvent MDR-1 both in vitro and in vivo. A liposomal formulation of Ann is currently in phase I clinical trials. The multidrug resistance-associated protein (MRP) has been found to be over-expressed in some hum